miR-1 and miR-133b expression in canine osteosarcoma

Area of Science:

• Veterinary Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma (OS) is the most prevalent primary malignant bone tumor in canines, comprising 80-85% of primitive bone tumors.
• Canine OS shares significant genetic, biologic, and clinical pathological similarities with human OS.
• MicroRNAs (miRNAs) are key regulators of gene expression, and their dysregulation is implicated in various cancers.

Purpose of the Study:

• To investigate the expression patterns of miR-1 and miR-133b in canine osteosarcoma.
• To determine the role of these miRNAs in osteogenesis and tumor cell proliferation in canine OS.
• To explore the potential of miR-1 and miR-133b as biomarkers for canine OS.

Main Methods:

• Analysis of miR-1 and miR-133b expression in canine OS tumor samples versus normal bone.
• Assessment of target gene expression (MET and MCL1) in relation to miRNA levels.
• Immunohistochemical evaluation of MET and MCL1 protein expression in tumor tissues.

Main Results:

• A decreased expression of miR-1 and miR-133b was observed in canine osteosarcoma tissues compared to normal bone.
• Conversely, elevated expression of their target genes, MET and MCL1, was detected in tumor samples.
• MET and MCL1 proteins showed moderate to strong immunostaining in over 50% of the analyzed canine OS samples.

Conclusions:

• The findings indicate a significant downregulation of miR-1 and miR-133b in canine osteosarcoma.
• The results support the role of MET and MCL1 as targets of miR-1 and miR-133b in canine OS.
• miR-1 and miR-133b show potential as diagnostic or prognostic biomarkers for canine osteosarcoma, mirroring findings in human OS.